APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Selected research

Market Structure

Global Glucagon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025181 pages

Choose your research edition.

Industry ResearchGlucagon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucagon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

This report provides an overview of the global Glucagon market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Glucagon and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucagon sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucagon market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucagon Segment by Company

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

Taj Pharmaceuticals

Xeris Pharmaceuticals

Glucagon Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Segment by Application

Emergency Kits

General Use

Diagnostic & Motility

Cardiogenic Shock

Others

Glucagon Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucagon market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glucagon Industry Trends Table 2. Glucagon Industry Drivers Table 3. Glucagon Industry Opportunities and Challenges Table 4. Glucagon Industry Restraints Table 5. Global Glucagon Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glucagon Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glucagon Sales by Manufacturers (K MT) & (2021-2026) Table 8. Global Glucagon Sales Market Share by Manufacturers Table 9. Global Glucagon Average Sales Price (USD/MT) of Manufacturers (2021-2026) Table 10. Global Glucagon Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glucagon Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glucagon Manufacturers, Product Type & Application Table 13. Global Glucagon Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucagon by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inject Glucagon Table 17. Major Manufacturers of Nasal Glucagon Table 18. Global Glucagon Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 19. Global Glucagon Sales by Type (2021-2026) & (K MT) Table 20. Global Glucagon Sales by Type (2027-2032) & (K MT) Table 21. Global Glucagon Sales Market Share by Type (2021-2026) Table 22. Global Glucagon Sales Market Share by Type (2027-2032) Table 23. Global Glucagon Revenue by Type 2021 VS 2025 VS 2032 (K MT) Table 24. Global Glucagon Revenue by Type (2021-2026) & (K MT) Table 25. Global Glucagon Revenue by Type (2027-2032) & (K MT) Table 26. Global Glucagon Revenue Market Share by Type (2021-2026) Table 27. Global Glucagon Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Emergency Kits Table 29. Major Manufacturers of General Use Table 30. Major Manufacturers of Diagnostic & Motility Table 31. Major Manufacturers of Cardiogenic Shock Table 32. Major Manufacturers of Others Table 33. Global Glucagon Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 34. Global Glucagon Sales by Application (2021-2026) & (K MT) Table 35. Global Glucagon Sales by Application (2027-2032) & (K MT) Table 36. Global Glucagon Sales Market Share by Application (2021-2026) Table 37. Global Glucagon Sales Market Share by Application (2027-2032) Table 38. Global Glucagon Revenue by Application 2021 VS 2025 VS 2032 (K MT) Table 39. Global Glucagon Revenue by Application (2021-2026) & (K MT) Table 40. Global Glucagon Revenue by Application (2027-2032) & (K MT) Table 41. Global Glucagon Revenue Market Share by Application (2021-2026) Table 42. Global Glucagon Revenue Market Share by Application (2027-2032) Table 43. Global Glucagon Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 44. Global Glucagon Sales by Region (2021-2026) & (K MT) Table 45. Global Glucagon Sales Market Share by Region (2021-2026) Table 46. Global Glucagon Sales Forecasted by Region (2027-2032) & (K MT) Table 47. Global Glucagon Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 49. North America Glucagon Sales by Country (2021-2026) & (K MT) Table 50. North America Glucagon Sales by Country (2027-2032) & (K MT) Table 51. Europe Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 52. Europe Glucagon Sales by Country (2021-2026) & (K MT) Table 53. Europe Glucagon Sales by Country (2027-2032) & (K MT) Table 54. Asia Pacific Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 55. Asia Pacific Glucagon Sales by Country (2021-2026) & (K MT) Table 56. Asia Pacific Glucagon Sales by Country (2027-2032) & (K MT) Table 57. South America, Middle East and Africa Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 58. South America, Middle East and Africa Glucagon Sales by Country (2021-2026) & (K MT) Table 59. South America, Middle East and Africa Glucagon Sales by Country (2027-2032) & (K MT) Table 60. Global Glucagon Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Glucagon Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Glucagon Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Glucagon Revenue Market Share by Region (2021-2026) Table 64. Global Glucagon Revenue Market Share by Region (2027-2032) Table 65. Novo Nordisk Company Information Table 66. Novo Nordisk Business Overview Table 67. Novo Nordisk Glucagon Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Novo Nordisk Glucagon Product Portfolio Table 69. Novo Nordisk Recent Development Table 70. Eli Lilly Company Information Table 71. Eli Lilly Business Overview Table 72. Eli Lilly Glucagon Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Eli Lilly Glucagon Product Portfolio Table 74. Eli Lilly Recent Development Table 75. Fresenius Kabi Company Information Table 76. Fresenius Kabi Business Overview Table 77. Fresenius Kabi Glucagon Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Fresenius Kabi Glucagon Product Portfolio Table 79. Fresenius Kabi Recent Development Table 80. Torrent Labs Company Information Table 81. Torrent Labs Business Overview Table 82. Torrent Labs Glucagon Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Torrent Labs Glucagon Product Portfolio Table 84. Torrent Labs Recent Development Table 85. Taj Pharmaceuticals Company Information Table 86. Taj Pharmaceuticals Business Overview Table 87. Taj Pharmaceuticals Glucagon Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Taj Pharmaceuticals Glucagon Product Portfolio Table 89. Taj Pharmaceuticals Recent Development Table 90. Xeris Pharmaceuticals Company Information Table 91. Xeris Pharmaceuticals Business Overview Table 92. Xeris Pharmaceuticals Glucagon Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Xeris Pharmaceuticals Glucagon Product Portfolio Table 94. Xeris Pharmaceuticals Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Glucagon Distributors List Table 98. Glucagon Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Glucagon Product Image Figure 2. Global Glucagon Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucagon Sales (2021-2032) & (K MT) Figure 5. Global Glucagon Average Price (USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Glucagon Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inject Glucagon Image Figure 9. Nasal Glucagon Image Figure 10. Global Glucagon Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 11. Global Glucagon Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Glucagon Sales Market Share by Type (2021-2032) Figure 13. Global Glucagon Revenue by Type (2021 VS 2025 VS 2032) & (K MT) Figure 14. Global Glucagon Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Glucagon Revenue Market Share by Type (2021-2032) Figure 16. Emergency Kits Image Figure 17. General Use Image Figure 18. Diagnostic & Motility Image Figure 19. Cardiogenic Shock Image Figure 20. Others Image Figure 21. Global Glucagon Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 22. Global Glucagon Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Glucagon Sales Market Share by Application (2021-2032) Figure 24. Global Glucagon Revenue by Application (2021 VS 2025 VS 2032) & (K MT) Figure 25. Global Glucagon Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Glucagon Revenue Market Share by Application (2021-2032) Figure 27. North America Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 28. North America Glucagon Sales Market Share by Country (2021-2032) Figure 29. U.S. Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 30. Canada Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 31. Mexico Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 32. Europe Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 33. Europe Glucagon Sales Market Share by Country (2021-2032) Figure 34. Germany Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 35. France Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 36. U.K. Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 37. Italy Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 38. Netherlands Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 39. Asia Pacific Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 40. Asia Pacific Glucagon Sales Market Share by Country (2021-2032) Figure 41. China Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 42. Japan Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 43. South Korea Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 44. Southeast Asia Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 45. India Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 46. Australia Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 47. South America, Middle East and Africa Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 48. South America, Middle East and Africa Glucagon Sales Market Share by Country (2021-2032) Figure 49. Brazil Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 50. South Africa Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 51. Saudi Arabia Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 52. Turkey Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 53. Argentina Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 54. UAE Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 55. Egypt Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 56. Chile Glucagon Sales and Growth Rate (2021-2032) & (K MT) Figure 57. Global Glucagon Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Glucagon Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Glucagon Revenue (2021-2032) & (US$ Million) Figure 60. North America Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Glucagon Revenue (2021-2032) & (US$ Million) Figure 62. Europe Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Glucagon Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Glucagon Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Glucagon Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Glucagon Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Emergency Kits
  • General Use
  • Diagnostic & Motility
  • Cardiogenic Shock
  • Others
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Taj Pharmaceuticals
  • Xeris Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glucagon Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glucagon Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glucagon Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glucagon Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glucagon Market Dynamics
  1. 2.1 Glucagon Industry Trends
  2. 2.2 Glucagon Industry Drivers
  3. 2.3 Glucagon Industry Opportunities and Challenges
  4. 2.4 Glucagon Industry Restraints
3 Glucagon Market by Manufacturers
  1. 3.1 Global Glucagon Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glucagon Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glucagon Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glucagon Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucagon Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glucagon Manufacturers, Product Type & Application
  7. 3.7 Global Glucagon Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucagon Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucagon Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucagon Tier 1, Tier 2, and Tier 3
4 Glucagon Market by Type
  1. 4.1 Glucagon Type Introduction
  2. 4.1.1 Inject Glucagon
  3. 4.1.2 Nasal Glucagon
  4. 4.2 Global Glucagon Sales by Type
  5. 4.2.1 Global Glucagon Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glucagon Sales by Type (2021-2032)
  7. 4.2.3 Global Glucagon Sales Market Share by Type (2021-2032)
  8. 4.3 Global Glucagon Revenue by Type
  9. 4.3.1 Global Glucagon Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glucagon Revenue by Type (2021-2032)
  11. 4.3.3 Global Glucagon Revenue Market Share by Type (2021-2032)
5 Glucagon Market by Application
  1. 5.1 Glucagon Application Introduction
  2. 5.1.1 Emergency Kits
  3. 5.1.2 General Use
  4. 5.1.3 Diagnostic & Motility
  5. 5.1.4 Cardiogenic Shock
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Sales by Application
  8. 5.2.1 Global Glucagon Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glucagon Sales by Application (2021-2032)
  10. 5.2.3 Global Glucagon Sales Market Share by Application (2021-2032)
  11. 5.3 Global Glucagon Revenue by Application
  12. 5.3.1 Global Glucagon Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glucagon Revenue by Application (2021-2032)
  14. 5.3.3 Global Glucagon Revenue Market Share by Application (2021-2032)
6 Global Glucagon Sales by Region
  1. 6.1 Global Glucagon Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucagon Sales by Region (2021-2032)
  3. 6.2.1 Global Glucagon Sales by Region (2021-2026)
  4. 6.2.2 Global Glucagon Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glucagon Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glucagon Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glucagon Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glucagon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glucagon Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glucagon Revenue by Region
  1. 7.1 Global Glucagon Revenue by Region
  2. 7.1.1 Global Glucagon Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glucagon Revenue by Region (2021-2026)
  4. 7.1.3 Global Glucagon Revenue by Region (2027-2032)
  5. 7.1.4 Global Glucagon Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glucagon Revenue (2021-2032)
  8. 7.2.2 North America Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glucagon Revenue (2021-2032)
  11. 7.3.2 Europe Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glucagon Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glucagon Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glucagon Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Glucagon Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Glucagon Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Glucagon Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Glucagon Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Glucagon Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Glucagon Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Torrent Labs
  20. 8.4.1 Torrent Labs Company Information
  21. 8.4.2 Torrent Labs Business Overview
  22. 8.4.3 Torrent Labs Glucagon Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Torrent Labs Glucagon Product Portfolio
  24. 8.4.5 Torrent Labs Recent Developments
  25. 8.5 Taj Pharmaceuticals
  26. 8.5.1 Taj Pharmaceuticals Company Information
  27. 8.5.2 Taj Pharmaceuticals Business Overview
  28. 8.5.3 Taj Pharmaceuticals Glucagon Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
  30. 8.5.5 Taj Pharmaceuticals Recent Developments
  31. 8.6 Xeris Pharmaceuticals
  32. 8.6.1 Xeris Pharmaceuticals Company Information
  33. 8.6.2 Xeris Pharmaceuticals Business Overview
  34. 8.6.3 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
  36. 8.6.5 Xeris Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucagon Value Chain Analysis
  2. 9.1.1 Glucagon Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucagon Production Mode & Process
  6. 9.2 Glucagon Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucagon Distributors
  9. 9.2.3 Glucagon Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst